Biological changes associated with healthy versus pathological aging: A symposium review

Ageing Research Reviews

Volumn 8, Issue 2, 2009, Pages 140-146

  Rajah, M N ^a   Bastianetto, S ^a   Bromley Brits, K ^b   Cools, R ^c   D'Esposito, M ^d   Grady, C L ^e   Poirier, J ^f   Quirion, R ^a   Raz, N ^g   Rogaeva, E ^h   Song, W ^b   Pruessner, J ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amyloid deposition; Dementia; Dopamine; Healthy aging; Hippocampus; MRI; Prefrontal cortex; Volumetry

Indexed keywords

AGING; BIOLOGICAL TRAIT; BRAIN REGION; BRAIN SIZE; CROSS FERTILIZATION; DEMENTIA; DOPAMINERGIC ACTIVITY; GENETICS; HUMAN; MEDICAL RESEARCH; NEUROBIOLOGY; NEUROSCIENCE; NONHUMAN; PREFRONTAL CORTEX; SHORT SURVEY;

AGING; BRAIN; DEMENTIA; DOPAMINE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MAGNETIC RESONANCE IMAGING; NEUROSCIENCES; ORGAN SIZE; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX;

EID: 61449231530     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2009.01.003     Document Type: Short Survey

References (63)

1. Bastianetto S., Brouillette J., and Quirion R. Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochem. Res. 32 10 (2007) 1720-1725
2. Bastianetto S., Yao Z.X., Papadopoulos V., and Quirion R. Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur. J. Neurosci. 23 1 (2006) 55-64
3. Bettens K., Brouwers N., Engelborghs S., De Deyn P.P., Van Broeckhoven C., and Sleegers K. SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Hum. Mutat. 29 5 (2008) 769-770
4. Bhatia S., Bookheimer S.Y., Gaillard W.D., and Theodore W.H. Measurement of whole temporal lobe and hippocampus for MR volumetry: normative data. Neurology 43 10 (1993) 2006-2010
5. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., and Zubieta J.K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 59 9 (2006) 812-815
6. Cabeza R. Hemispheric asymmetry reduction in older adults: the HAROLD model. Psychol. Aging 17 1 (2002) 85-100
7. Cabeza R., Daselaar S.M., Dolcos F., Prince S.E., Budde M., and Nyberg L. Task-independent and task-specific age effects on brain activity during working memory, visual attention and episodic retrieval. Cereb. Cortex 14 4 (2004) 364-375
8. Chen A.J., Abrams G.M., and D'Esposito M. Functional reintegration of prefrontal neural networks for enhancing recovery after brain injury. J. Head Trauma Rehabil. 21 2 (2006) 107-118
9. Christensen M.A., Zhou W., Qing H., Lehman A., Philipsen S., and Song W. Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol. Cell. Biol. 24 2 (2004) 865-874
10. Colcombe S.J., Erickson K.I., Raz N., Webb A.G., Cohen N.J., McAuley E., and Kramer A.F. Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci 58 2 (2003) 176-180
11. Colcombe S.J., Kramer A.F., Erickson K.I., and Scalf P. The implications of cortical recruitment and brain morphology for individual differences in inhibitory function in aging humans. Psychol. Aging 20 3 (2005) 363-375
12. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci. Biobehav. Rev. 30 1 (2006) 1-23
13. Cools R., Barker R.A., Sahakian B.J., and Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb. Cortex 11 12 (2001) 1136-1143
14. Cools R., Barker R.A., Sahakian B.J., and Robbins T.W. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 41 11 (2003) 1431-1441
15. Cools R., Lewis S.J., Clark L., Barker R.A., and Robbins T.W. L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 32 1 (2007) 180-189
16. Daselaar S.M., Fleck M.S., Dobbins I.G., Madden D.J., and Cabeza R. Effects of healthy aging on hippocampal and rhinal memory functions: an event-related fMRI study. Cereb. Cortex (2006)
17. D'Esposito M., and Gazzaley A. Neurorehabilitation and executive function. In: Selzer M.E., Cohen L., Gage F.H., Clarke S., and Duncan P.W. (Eds). Neural Rehabilitation and Repair (2006), Cambridge University Press, Cambridge, UK 475-487
18. Duncan J., Emslie H., Williams P., Johnson R., and Freer C. Intelligence and the frontal lobe: the organization of goal-directed behavior. Cognit. Psychol. 30 3 (1996) 257-303
19. Erickson K.I., Colcombe S.J., Raz N., Korol D.L., Scalf P., Webb A., Cohen N.J., McAuley E., and Kramer A.F. Selective sparing of brain tissue in postmenopausal women receiving hormone replacement therapy. Neurobiol Aging 26 8 (2005) 1205-1213
20. Erickson K.I., Colcombe S.J., Wadhwa R., Bherer L., Peterson M.S., Scalf P.E., Kim J.S., Alvarado M., and Kramer A.F. Training-induced plasticity in older adults: effects of training on hemispheric asymmetry. Neurobiol. Aging 28 2 (2007) 272-283
21. Gazzaley A., Cooney J.W., Rissman J., and D'Esposito M. Top down suppression deficit underlies working memory impairment in normal aging. Nat Neurosci 8 10 (2005) 1298-1300
22. Grady C.L., McIntosh A.R., and Craik F.I. Task-related activity in prefrontal cortex and its relation to recognition memory performance in young and old adults. Neuropsychologia 43 10 (2005) 1466-1481
23. Grady C.L., McIntosh A.R., Horwitz B., Maisog J.M., Ungerleider L.G., Mentis M.J., Pietrini P., Schapiro M.B., and Haxby J.V. Age-related reductions in human recognition memory due to impaired encoding. Science 269 (1995) 218-220
24. Grady C.L., Yu H., and Alain C. Age-related differences in brain activity underlying working memory for spatial and nonspatial auditory information. Cereb. Cortex 18 1 (2008) 189-199
25. Greenwood P.M. Functional plasticity in cognitive aging: review and hypothesis. Neuropsychology 21 6 (2007) 657-673
26. Greenwood P.M., and Parasuraman R. Normal genetic variation, cognition, and aging. Behav. Cogn. Neurosci. Rev. 2 4 (2003) 278-306
27. Ikonomovic M.D., Klunk W.E., Abrahamson E.E., Mathis C.A., Price J.C., Tsopelas N.D., Lopresti B.J., Ziolko S., Bi W., Paljug W.R., et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 131 Pt 6 (2008) 1630-1645
28. Jack Jr. C.R., Dickson D.W., Parisi J.E., Xu Y.C., Cha R.H., O'Brien P.C., Edland S.D., Smith G.E., Boeve B.F., Tangalos E.G., et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58 5 (2002) 750-757
29. Jack Jr. C.R., Theodore W.H., Cook M., and McCarthy G. MRI-based hippocampal volumetrics: data acquisition, normal ranges, and optimal protocol. Magn. Reson. Imag. 13 8 (1995) 1057-1064
30. Jernigan T.L., Archibald S.L., Fennema-Notestine C., Gamst A.C., Stout J.C., Bonner J., and Hesselink J.R. Effects of age on tissues and regions of the cerebrum and cerebellum. Neurobiol. Aging 22 4 (2001) 581-594
31. Joober R., Gauthier J., Lal S., Bloom D., Lalonde P., Rouleau G., Benkelfat C., and Labelle A. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch. Gen. Psychiatry 59 7 (2002) 662-663
32. Levine B., Cabeza R., McIntosh A.R., Black S.E., Grady C.L., and Stuss D.T. Functional reorganisation of memory after traumatic brain injury: a study with H(2)(15)0 positron emission tomography. J. Neurol. Neurosurg. Psychiatry 73 2 (2002) 173-181
33. Levine B., Robertson I.H., Clare L., Carter G., Hong J., Wilson B.A., Duncan J., and Stuss D.T. Rehabilitation of executive functioning: an experimental-clinical validation of goal management training. J. Int. Neuropsychol. Soc. 6 3 (2000) 299-312
34. Levine B., Stuss D.T., Winocur G., Binns M.A., Fahy L., Mandic M., Bridges K., and Robertson I.H. Cognitive rehabilitation in the elderly: effects on strategic behavior in relation to goal management. J. Int. Neuropsychol. Soc. 13 1 (2007) 143-152
35. MacDonald III A.W., Carter C.S., Flory J.D., Ferrell R.E., and Manuck S.B. COMT val158Met and executive control: a test of the benefit of specific deficits to translational research. J. Abnorm. Psychol. 116 2 (2007) 306-312
36. Meng Y., Lee J.H., Cheng R., St George-Hyslop P., Mayeux R., and Farrer L.A. Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport 18 17 (2007) 1761-1764
37. Meyer-Lindenberg A., Nichols T., Callicott J.H., Ding J., Kolachana B., Buckholtz J., Mattay V.S., Egan M., and Weinberger D.R. Impact of complex genetic variation in COMT on human brain function. Mol. Psychiatry 11 9 (2006) 867-77, 797
38. Miller E.K., and Cohen J.D. An integrative theory of prefrontal cortex function. Ann. Rev. Neurosci. 24 (2001) 167-202
39. Moffat S.D., Szekely C.A., Zonderman A.B., Kabani N.J., and Resnick S.M. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology 55 1 (2000) 134-136
40. Morcom A.M., Li J., and Rugg M.D. Age effects on the neural correlates of episodic retrieval: increased cortical recruitment with matched performance. Cereb. Cortex 17 11 (2007) 2491-2506
41. Mu Q., Xie J., Wen Z., Weng Y., and Shuyun Z. A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. AJNR 20 2 (1999) 207-211
42. Nicolaou M., Song Y.Q., Sato C.A., Orlacchio A., Kawarai T., Medeiros H., Liang Y., Sorbi S., Richard E., Rogaev E.I., et al. Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease. Neurogenetics 3 4 (2001) 203-206
43. Nordberg A. Amyloid imaging in Alzheimer's disease. Curr. Opin. Neurol. 20 4 (2007) 398-402
44. Persson J., Nyberg L., Lind J., Larsson A., Nilsson L.G., Ingvar M., and Buckner R.L. Structure-function correlates of cognitive decline in aging. Cereb. Cortex 16 7 (2006) 907-915
45. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17 12 (1994) 525-530
46. Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol. Med. 9 3 (2003) 94-101
47. Poirier J., Delisle M.C., Quirion R., Aubert I., Farlow M., Lahiri D., Hui S., Bertrand P., Nalbantoglu J., Gilfix B.M., et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 92 26 (1995) 12260-12264
48. Pruessner J.C., Baldwin M.W., Dedovic K., Renwick R., Mahani N.K., Lord C., Meaney M., and Lupien S. Self-esteem, locus of control, hippocampal volume, and cortisol regulation in young and old adulthood. Neuroimage 28 4 (2005) 815-826
49. Pruessner J.C., Collins D.L., Pruessner M., and Evans A.C. Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood. J. Neurosci. 21 1 (2001) 194-200
50. Qing H., Zhou W., Christensen M.A., Sun X., Tong Y., and Song W. Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J. 18 13 (2004) 1571-1573
51. Rajah M.N., and D'Esposito M. Region-specific changes in prefrontal function with age: a review of PET and fMRI studies on working and episodic memory. Brain 128 Pt 9 (2005) 1964-1983
52. Raz N., Rodrigue K.M., Head D., Kennedy K.M., and Acker J.D. Differential aging of the medial temporal lobe: a study of a five-year change. Neurology 62 3 (2004) 433-438
53. Raz N., Gunning-Dixon F., Head D., Rodrigue K.M., Williamson A., and Acker J.D. Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume. Neurobiol Aging 25 3 (2004) 377-396
54. Raz N., Lindenberger U., Rodrigue K.M., Kennedy K.M., Head D., Williamson A., Dahle C., Gerstorf D., and Acker J.D. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. Cereb Cortex 15 11 (2005) 1676-1689
55. Raz N., Rodrigue K.M., and Haacke E.M. Brain aging and its modifiers: insights from in vivo neuromorphometry and susceptibility weighted imaging. Ann N Y Acad Sci 1097 (2007) 84-93
56. Rogaeva E., Meng Y., Lee J.H., Gu Y., Kawarai T., Zou F., Katayama T., Baldwin C.T., Cheng R., Hasegawa H., et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39 2 (2007) 168-177
57. Rypma B., Eldreth D.A., and Rebbechi D. Age-related differences in activation-performance relations in delayed-response tasks: a multiple component analysis. Cortex 43 1 (2007) 65-76
58. Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L.E., and Song W. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 103 49 (2006) 18727-18732
59. Tan E.K., Lee J., Chen C.P., Teo Y.Y., Zhao Y., and Lee W.L. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese. Neurobiol. Aging (2007)
60. Tong Y., Zhou W., Fung V., Christensen M.A., Qing H., Sun X., and Song W. Oxidative stress potentiates BACE1 gene expression and Abeta generation. J. Neural Transm. 112 3 (2005) 455-469
61. Townsend J., Adamo M., and Haist F. Changing channels: an fMRI study of aging and cross-modal attention shifts. Neuroimage 31 4 (2006) 1682-1692
62. van Hooren S.A., Valentijn S.A., Bosma H., Ponds R.W., van Boxtel M.P., Levine B., Robertson I., and Jolles J. Effect of a structured course involving goal management training in older adults: a randomised controlled trial. Patient Educ. Couns. 65 2 (2007) 205-213
63. Zhou W., and Song W. Leaky scanning and reinitiation regulate BACE1 gene expression. Mol. Cell. Biol. 26 9 (2006) 3353-3364